Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22361,174,1.39 [1.10-1.75],0.0054574961860955
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23385,184,1.15 [0.92-1.45],0.2140118064766933
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23138,1403,1.25 [1.15-1.35],1.480596031198649e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23395,373,1.10 [0.94-1.29],0.2290578319879635
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22709,3430,1.16 [1.10-1.22],2.386001372840673e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22679,3461,1.22 [1.16-1.29],7.833501199191941e-14
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23188,1030,1.11 [1.01-1.22],0.0344166126129912
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23322,78,1.07 [0.76-1.52],0.6970716365203854
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21198,1108,1.25 [1.14-1.37],2.111034958008124e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20449,1228,1.34 [1.23-1.47],7.094819188195007e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20175,249,1.26 [1.04-1.53],0.0194946087688547
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16462,2246,1.21 [1.14-1.30],4.622027604172499e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20106,404,1.51 [1.30-1.76],1.0295434671708264e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23386,1228,1.11 [1.01-1.21],0.0241804151567767
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,23485,463,1.10 [0.96-1.27],0.1698011431927371
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22621,886,1.27 [1.14-1.41],6.153931853257748e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23407,1220,1.23 [1.13-1.35],2.8387348438441504e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22344,186,1.15 [0.92-1.44],0.2225839110140941
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23524,53,1.29 [0.84-1.96],0.2446846190263529
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23257,1070,1.22 [1.11-1.34],4.78216951261679e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23313,69,1.34 [0.93-1.93],0.1209298911605836
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23461,118,1.22 [0.93-1.62],0.1577918555870507
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23443,100,1.44 [1.07-1.95],0.0167865838515739
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22221,486,1.34 [1.16-1.53],4.260714374492419e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22023,288,1.31 [1.09-1.57],0.0034305512371456
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22246,88,1.32 [0.95-1.83],0.0945922238330464
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23505,65,1.77 [1.22-2.56],0.0027121578787378
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23470,142,1.20 [0.93-1.55],0.1692007005092358
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,23380,52,1.05 [0.69-1.61],0.8226654833327565
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23379,51,1.26 [0.82-1.94],0.2864389973945172
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,23213,338,1.11 [0.94-1.31],0.2342131194667416
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23453,44,1.17 [0.74-1.84],0.5110502178810815
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23422,54,0.88 [0.59-1.33],0.546781473876077
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23478,129,1.21 [0.92-1.59],0.16666140609908
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23157,1618,0.92 [0.86-1.00],0.0368552997498337
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,23524,33,1.03 [0.61-1.76],0.905828601801836
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23463,64,1.09 [0.74-1.59],0.6688629352962747
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23508,76,1.09 [0.77-1.55],0.6279555439106883
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23499,435,0.91 [0.79-1.06],0.2242094832656421
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,23495,333,0.84 [0.71-0.99],0.0393340052637346
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23398,81,0.69 [0.50-0.96],0.0275622056158307
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23491,273,0.82 [0.68-0.98],0.0308059253838738
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,23451,416,0.92 [0.79-1.07],0.2634635691609534
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23402,718,0.91 [0.82-1.03],0.1253064465493982
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23481,551,0.82 [0.72-0.94],0.0034516636529314
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18284,71,0.91 [0.64-1.31],0.6253217359842305
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18283,70,0.96 [0.66-1.39],0.8245990263568622
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23493,100,1.31 [0.97-1.78],0.0816863656775241
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",23493,97,1.27 [0.93-1.73],0.1320141115696987
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,15643,338,1.27 [1.08-1.50],0.0045254803314614
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,18278,65,0.87 [0.60-1.27],0.4774499645914732
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18405,192,1.00 [0.80-1.25],0.972660540080495
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18504,291,1.06 [0.89-1.27],0.5056942226249137
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18304,91,1.21 [0.88-1.67],0.2393604384429628
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18356,143,0.98 [0.76-1.26],0.8645337570273782
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18352,139,1.09 [0.84-1.41],0.5181274094977404
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18294,81,0.84 [0.60-1.18],0.3149570861900822
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19596,1383,0.95 [0.88-1.03],0.2512399903296038
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18354,141,0.78 [0.60-1.00],0.0544058895575838
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18319,106,0.97 [0.72-1.30],0.8265691810731539
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18340,127,0.69 [0.53-0.90],0.0069097288696575
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,23400,163,1.08 [0.85-1.37],0.5221293324491805
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,23493,92,1.15 [0.83-1.58],0.4017514566706833
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanoma in situ,18242,69,1.13 [0.78-1.64],0.5189772824323076
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18313,100,0.95 [0.70-1.29],0.7516984593713417
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18379,166,0.99 [0.78-1.26],0.9282855145845228
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18428,215,1.15 [0.94-1.42],0.1784849708839674
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18313,100,1.07 [0.78-1.45],0.6876443637111284
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,23390,139,0.78 [0.60-1.00],0.0518085287122765
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19405,1192,0.94 [0.86-1.03],0.1783116467490261
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19477,1264,0.95 [0.87-1.03],0.2204410632328775
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23253,305,0.97 [0.81-1.15],0.7238024357580694
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21804,116,1.94 [1.46-2.57],4.663656802640567e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23019,71,1.13 [0.78-1.62],0.5219146429724191
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22974,2753,1.21 [1.14-1.29],1.186813698228251e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22264,62,0.99 [0.67-1.46],0.9577062384081252
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23105,51,1.18 [0.77-1.82],0.4456442802525773
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23150,1462,1.16 [1.07-1.25],0.000388449437817
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23148,1460,1.16 [1.07-1.25],0.0004301739135405
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21793,105,1.54 [1.14-2.07],0.0050783840121704
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23286,1084,1.37 [1.25-1.50],3.2337687493223065e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23155,101,0.79 [0.58-1.06],0.117347401808788
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23021,73,1.13 [0.79-1.61],0.5099755649004256
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23008,60,1.10 [0.74-1.64],0.6384144636090927
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23364,310,1.34 [1.13-1.60],0.0009706136965593
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23429,48,1.30 [0.84-2.00],0.2417325094504139
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23305,251,1.32 [1.09-1.60],0.0050113873196396
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22280,78,0.98 [0.69-1.39],0.8996866304001704
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17347,371,1.52 [1.30-1.78],2.7217048315624294e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21505,162,0.82 [0.65-1.03],0.0928438291759216
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21532,189,0.73 [0.60-0.89],0.0021779029609259
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17033,57,1.60 [1.06-2.40],0.0247297951593613
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22164,64,1.86 [1.28-2.70],0.0011527174112612
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21411,216,1.03 [0.83-1.27],0.798223056254215
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23023,610,1.19 [1.05-1.35],0.0062386189079818
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22653,240,1.03 [0.84-1.26],0.8063829160879926
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22581,168,0.94 [0.74-1.20],0.6446320939281274
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23225,1125,1.09 [0.99-1.19],0.0653634617757322
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20120,1082,1.09 [0.99-1.19],0.0828849534048071
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17049,73,1.10 [0.77-1.58],0.5893332848045495
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22656,39,1.17 [0.72-1.91],0.5335843812485868
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17245,269,1.28 [1.06-1.54],0.0109465187480807
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17050,74,1.45 [1.01-2.08],0.0423629180781826
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20805,3829,1.00 [0.95-1.05],0.8971164864152358
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17158,182,1.29 [1.02-1.62],0.0311182261032194
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17538,562,1.23 [1.08-1.40],0.0019416377313629
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23467,269,1.38 [1.15-1.66],0.0006745625061809
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23286,88,1.80 [1.30-2.49],0.0003455236369395
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17127,151,1.07 [0.83-1.37],0.618902678550558
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17041,65,1.41 [0.96-2.08],0.0777585246872212
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23350,733,1.08 [0.97-1.21],0.164173064543101
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17276,300,1.49 [1.25-1.79],1.0159962238823044e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17349,373,1.36 [1.16-1.59],0.0001874245446645
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17691,715,1.03 [0.92-1.16],0.6162770099617376
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17120,144,1.64 [1.27-2.13],0.0001562653495045
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23279,81,1.69 [1.21-2.37],0.0023321634934272
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17533,557,1.40 [1.23-1.60],4.411610607214431e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17363,387,1.11 [0.95-1.30],0.1875123806601496
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21260,65,1.06 [0.73-1.56],0.7482384321611966
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22103,5127,1.04 [1.00-1.09],0.0688378578411212
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22636,19,0.99 [0.49-2.00],0.9666707808454936
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22639,22,1.27 [0.67-2.41],0.4701946681464558
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23357,1752,0.95 [0.88-1.02],0.1705701057376796
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23354,1748,0.95 [0.89-1.02],0.1883500526111787
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22639,22,0.81 [0.42-1.55],0.521396851856587
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23255,789,1.12 [1.01-1.25],0.0377263387932171
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18572,1596,1.32 [1.22-1.42],2.353557467222656e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23513,263,2.06 [1.71-2.48],3.0720913279483505e-14
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22521,108,1.01 [0.75-1.35],0.9733869520744434
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22539,73,1.42 [0.99-2.03],0.0558243677772174
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22547,81,1.22 [0.87-1.71],0.2579164656090406
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17039,63,1.61 [1.09-2.37],0.0170115084792416
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20758,161,2.05 [1.62-2.61],3.109353402871514e-09
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2476,122,1.57 [1.18-2.07],0.0017449900726955
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2641,320,1.56 [1.31-1.85],4.2053851133198454e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20696,99,1.91 [1.41-2.60],3.350416271191634e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2433,81,1.97 [1.40-2.76],9.294616209336523e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22750,2153,1.09 [1.02-1.17],0.0086593060543189
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22772,359,1.16 [0.99-1.37],0.0735823687422015
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21436,241,1.12 [0.93-1.37],0.234571172912129
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17770,794,1.22 [1.09-1.36],0.0003452496110909
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23401,248,1.40 [1.15-1.70],0.0006938046514939
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22323,271,1.29 [1.07-1.55],0.0084933405918536
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20644,1477,1.05 [0.97-1.14],0.2250523383330754
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22429,377,1.19 [1.01-1.40],0.0323962119406626
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22136,84,1.14 [0.81-1.58],0.4555557567727415
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22296,244,1.24 [1.02-1.50],0.033180500772814
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13774,2273,1.16 [1.09-1.24],4.164669799398444e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,18936,621,1.25 [1.10-1.42],0.000447915368485
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23451,530,1.05 [0.92-1.20],0.4754134166950813
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11751,250,1.39 [1.15-1.70],0.0008489886076996
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18518,203,1.14 [0.92-1.42],0.2255452673116488
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18426,111,1.28 [0.96-1.72],0.0924983102740112
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23525,64,1.05 [0.71-1.54],0.8122645395395378
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,19665,1350,1.20 [1.10-1.31],2.3755189025850903e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21734,2591,1.01 [0.95-1.08],0.6568477765335401
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19813,7660,1.03 [1.00-1.07],0.0820275177693698
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22313,272,1.45 [1.20-1.75],8.844458825992612e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,18397,82,1.28 [0.91-1.81],0.1568125283751898
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23215,1309,1.23 [1.13-1.34],2.036518174071336e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,21000,6686,1.02 [0.99-1.06],0.2179178568277343
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21021,6707,1.03 [0.99-1.07],0.1708169728790104
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23302,109,1.38 [1.03-1.84],0.0333995714447189
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14495,181,1.44 [1.14-1.81],0.0021941478121937
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14481,167,2.59 [2.03-3.30],1.1016233166669734e-14
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,23381,1228,1.24 [1.14-1.36],1.255525487082483e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22461,117,1.25 [0.94-1.66],0.1224710036103865
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21872,2705,1.00 [0.94-1.06],0.9643745651352452
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23095,648,1.23 [1.09-1.39],0.0008664083259954
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18729,414,1.17 [1.00-1.36],0.0440415372013898
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22794,1049,0.93 [0.84-1.02],0.106428779197774
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20079,912,0.97 [0.87-1.07],0.5099695045195075
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23363,220,0.95 [0.77-1.16],0.6110834336411567
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23472,376,1.06 [0.91-1.24],0.4592236104082446
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22110,69,1.34 [0.92-1.94],0.1225818298973239
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,22149,97,1.00 [0.73-1.36],0.9858094673478232
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,18789,474,1.29 [1.12-1.49],0.0005104615160406
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22183,131,1.07 [0.82-1.40],0.6065645658881785
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22332,280,1.38 [1.15-1.65],0.0005612690429872
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18505,190,1.11 [0.89-1.40],0.344052840548092
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22139,98,1.49 [1.10-2.03],0.0108231592323883
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22090,49,1.20 [0.78-1.86],0.4025291600518189
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21947,90,0.87 [0.63-1.20],0.402695992763022
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22147,106,1.57 [1.17-2.10],0.0028502146792781
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19552,1237,1.24 [1.13-1.35],2.1254113221029948e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22215,62,1.89 [1.29-2.77],0.001144007637303
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22611,559,1.19 [1.04-1.35],0.009587196526314
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22880,356,1.51 [1.29-1.78],5.312305307148356e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22522,665,1.25 [1.11-1.41],0.0002445316792987
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11880,379,1.33 [1.14-1.56],0.0004247105840634
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22525,520,1.19 [1.04-1.36],0.0103036097890493
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22391,350,1.42 [1.21-1.68],2.23993122252512e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23022,498,1.28 [1.12-1.47],0.000356063791907
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23462,702,1.10 [0.98-1.23],0.1194103742452508
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18779,464,1.29 [1.12-1.49],0.0004645924198227
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22878,354,1.51 [1.29-1.78],5.719142425398292e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22077,220,1.28 [1.04-1.58],0.0175966086414244
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23080,736,1.23 [1.09-1.37],0.0004238578899469
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23064,763,1.21 [1.08-1.35],0.0010108876363844
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22436,43,1.00 [0.63-1.60],0.9948116805894388
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22163,112,1.13 [0.85-1.52],0.4025331635049908
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22697,250,1.20 [0.99-1.46],0.0678739430504173
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22055,310,0.97 [0.82-1.16],0.7464482304281395
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,22412,371,1.35 [1.15-1.58],0.0002226872969077
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22069,74,1.17 [0.82-1.68],0.3796621453327933
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23288,777,1.33 [1.19-1.48],4.867576679232952e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23329,492,0.78 [0.69-0.90],0.0004424062063824
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20210,954,1.13 [1.02-1.25],0.0182597509164343
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,22845,3589,1.04 [0.99-1.09],0.164033539290458
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23267,581,0.81 [0.71-0.91],0.00069501426346
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20417,1161,1.11 [1.02-1.22],0.0193779486785388
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19338,82,1.57 [1.12-2.19],0.0083351730841978
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,22881,1514,1.02 [0.94-1.10],0.657783562563623
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21104,1848,0.97 [0.91-1.05],0.481920971115682
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,23018,150,1.28 [0.99-1.65],0.0594880516274767
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,23523,296,1.09 [0.91-1.30],0.3735316774368604
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15636,58,0.96 [0.63-1.45],0.8336264036173664
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,22174,76,1.16 [0.82-1.64],0.4028575163578828
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22436,338,0.87 [0.74-1.03],0.1108116817071075
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,23128,234,1.09 [0.89-1.33],0.4147024607385379
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23438,363,1.10 [0.94-1.29],0.2339857665362338
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23016,60,0.89 [0.60-1.33],0.5768160458312908
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23504,74,0.93 [0.65-1.33],0.704199679747221
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22984,90,1.21 [0.88-1.67],0.2488127061574126
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,21925,284,1.13 [0.94-1.35],0.1981018382450524
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22994,1353,1.16 [1.06-1.26],0.0005673841416094
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23490,672,1.04 [0.92-1.17],0.5161612964633553
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22980,2187,1.12 [1.05-1.19],0.0009141765011214
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23141,60,1.37 [0.92-2.02],0.1180633420112004
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,23356,281,1.24 [1.03-1.49],0.0199873212723135
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,22948,54,0.85 [0.56-1.28],0.4340561592884921
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23507,60,1.07 [0.72-1.59],0.7335158001465905
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22119,21,0.93 [0.48-1.81],0.8333241083266596
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22188,90,1.15 [0.84-1.59],0.3862229894051888
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,22857,120,1.15 [0.87-1.52],0.337826181793345
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,21834,193,1.06 [0.85-1.32],0.5935430402274783
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23500,174,1.09 [0.86-1.37],0.4723719963818931
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,15739,148,1.11 [0.86-1.43],0.4420353998773055
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23416,62,0.90 [0.61-1.32],0.5892989834631615
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23063,965,1.02 [0.92-1.12],0.6982482345757045
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,22232,3630,1.08 [1.03-1.14],0.0027311296516292
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23197,241,1.22 [1.00-1.48],0.0518278052872531
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22481,383,1.10 [0.94-1.29],0.2204170952266946
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23434,352,1.33 [1.13-1.57],0.0005760639810542
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18457,620,1.17 [1.03-1.33],0.0141213825691723
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22972,78,0.99 [0.70-1.40],0.9677232533661592
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23045,151,1.20 [0.94-1.54],0.1512950061925396
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22956,138,0.92 [0.71-1.20],0.5595293666007854
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22193,95,1.20 [0.88-1.63],0.2561954221203127
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,21679,38,1.08 [0.65-1.77],0.7740108589887498
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,23409,515,1.05 [0.92-1.21],0.4529345723411067
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,22336,695,1.13 [1.01-1.27],0.0372479978973199
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,23502,526,1.07 [0.93-1.22],0.3605127271512792
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22920,26,0.95 [0.52-1.73],0.8715285528503008
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23524,51,0.94 [0.61-1.44],0.760463197912804
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,23226,625,1.12 [0.99-1.26],0.0655303209767302
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23139,57,1.37 [0.91-2.06],0.1356779890327749
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23507,174,1.12 [0.88-1.41],0.3511924563338429
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22131,33,1.11 [0.65-1.89],0.7131028570218094
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23523,299,1.07 [0.89-1.28],0.4644522528601048
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22987,146,1.31 [1.01-1.70],0.0385606291104246
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22978,85,1.21 [0.86-1.69],0.2675086231751431
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23181,295,1.08 [0.90-1.29],0.4049098210704338
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23325,294,1.64 [1.38-1.96],2.870022731274308e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22663,44,0.87 [0.55-1.39],0.5715058541430091
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22680,61,1.09 [0.74-1.61],0.6553527880968807
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23432,42,1.11 [0.69-1.78],0.6622365525029142
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23292,119,0.96 [0.72-1.27],0.7571284579641457
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2437,83,2.06 [1.47-2.88],2.4321019454551952e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2977,130,1.44 [1.10-1.88],0.0076106501615237
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22987,94,0.80 [0.59-1.09],0.1559923704306708
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23279,988,1.26 [1.14-1.39],4.121491097818122e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23223,604,1.02 [0.90-1.16],0.7257333308763654
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22759,140,0.99 [0.76-1.28],0.9211324302517097
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23449,563,1.03 [0.91-1.17],0.6420993075994545
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23521,65,1.08 [0.74-1.57],0.7051859559340727
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23380,494,1.08 [0.94-1.24],0.306136227131668
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23484,311,1.17 [0.98-1.39],0.0782230773318546
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23436,150,1.24 [0.97-1.60],0.0921943084506269
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22695,76,0.93 [0.66-1.33],0.7100446642417815
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22702,83,1.04 [0.74-1.46],0.8169998414646984
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22662,43,0.85 [0.53-1.37],0.5140952337665058
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23436,669,1.11 [0.99-1.25],0.0847662614927325
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22947,180,0.98 [0.78-1.23],0.8569877264756421
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22915,29,0.83 [0.47-1.47],0.5261307123631114
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23269,96,1.32 [0.96-1.80],0.0842275937044394
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23395,222,1.13 [0.91-1.38],0.264958899386944
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23054,168,1.16 [0.92-1.48],0.2139623892567814
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23370,84,1.36 [0.97-1.91],0.0708400161203134
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23220,453,1.22 [1.06-1.41],0.0063731771593189
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23021,128,1.29 [0.99-1.69],0.0608193499585498
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22168,1768,1.13 [1.05-1.22],0.0011819835885691
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23364,191,1.06 [0.85-1.33],0.5944755139306757
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23508,146,1.25 [0.97-1.61],0.0811620532504629
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23030,411,0.97 [0.83-1.13],0.7052883453131884
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23238,65,1.33 [0.91-1.96],0.1408803983434715
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23510,54,1.10 [0.72-1.67],0.6649854294664352
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22693,74,1.09 [0.76-1.56],0.6560109541558014
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22757,138,0.94 [0.73-1.22],0.6553785716279813
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22420,129,1.16 [0.89-1.53],0.2784184051946622
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22937,51,0.76 [0.50-1.16],0.2083096598454467
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22354,63,1.18 [0.80-1.74],0.4113238396324303
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22816,49,0.99 [0.64-1.54],0.9603629498558738
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22968,201,0.97 [0.78-1.20],0.7635696226182935
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22737,118,0.97 [0.73-1.28],0.8183026005230644
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22413,122,1.04 [0.79-1.38],0.764729161105719
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22383,92,1.41 [1.02-1.95],0.0379627556124643
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21854,1454,1.10 [1.01-1.19],0.027818216702849
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22676,57,0.93 [0.62-1.40],0.7171653640253155
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23278,385,1.14 [0.97-1.33],0.10639731219417
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22963,70,1.31 [0.91-1.89],0.1415396114977226
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23062,169,1.20 [0.95-1.52],0.1198996043640008
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23347,58,1.09 [0.73-1.63],0.6720411227857666
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23483,117,1.08 [0.82-1.44],0.5761212627853569
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23390,113,1.16 [0.87-1.54],0.3138575216804979
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23339,50,1.02 [0.66-1.57],0.9219632946162016
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23343,54,1.38 [0.91-2.09],0.128583537380915
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23430,964,1.03 [0.93-1.14],0.5517591084927573
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23178,712,1.07 [0.96-1.20],0.2347450028559406
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22594,128,0.94 [0.71-1.23],0.6334511889455955
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22552,86,0.88 [0.64-1.23],0.4586877617426956
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23315,63,1.28 [0.87-1.88],0.2067722657757996
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23442,190,1.26 [1.01-1.57],0.0429482839499995
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23314,62,1.40 [0.95-2.06],0.0896414785064107
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,21249,107,1.88 [1.40-2.53],3.0505493499427992e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21246,104,1.85 [1.37-2.51],5.801924147183395e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15411,106,0.87 [0.65-1.17],0.3691036915592123
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23418,267,1.07 [0.89-1.29],0.4528142353757033
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16381,1421,1.02 [0.94-1.11],0.5703309406639265
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16700,1395,1.04 [0.96-1.13],0.3657779340465787
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23138,148,1.12 [0.87-1.44],0.3705590230708426
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21237,95,1.30 [0.95-1.78],0.1071492031822741
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,20439,287,1.26 [1.05-1.52],0.0124206705012334
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20195,43,1.13 [0.71-1.81],0.6072982880207043
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22688,2536,1.09 [1.02-1.16],0.0069900800702615
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22096,79,1.01 [0.72-1.42],0.95613721471631
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22176,159,0.86 [0.68-1.09],0.2146410267636481
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23300,1300,1.19 [1.09-1.30],6.033087847471885e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22152,135,1.09 [0.84-1.42],0.5133595570527492
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21547,5233,1.11 [1.07-1.16],6.211671572965508e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22403,386,1.10 [0.94-1.28],0.233122344329454
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,22308,308,1.16 [0.98-1.38],0.091155014288499
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,20497,345,1.44 [1.22-1.69],1.788994129438615e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22612,333,1.79 [1.51-2.11],1.2047848391406456e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23278,2136,1.24 [1.16-1.32],3.288353160579046e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22640,361,1.78 [1.51-2.09],2.491231796925309e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22462,992,1.18 [1.07-1.30],0.0009947134769975
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23506,422,1.27 [1.09-1.47],0.0018580666263903
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,22160,143,0.94 [0.73-1.22],0.6561206667969033
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23257,995,1.36 [1.23-1.50],7.145381052196385e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23249,2182,1.20 [1.13-1.29],3.0386891206838055e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22878,861,1.05 [0.95-1.16],0.3661037643684612
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,21131,64,1.49 [1.01-2.19],0.0445839285789679
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23433,443,1.66 [1.44-1.92],7.047085651533951e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23403,1389,1.18 [1.09-1.28],7.286285130234496e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,22172,1105,1.24 [1.13-1.36],5.875232871621876e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,21332,265,1.34 [1.11-1.63],0.0024784936399131
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23014,1872,1.23 [1.15-1.32],8.622252618535677e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23408,324,1.34 [1.13-1.59],0.0007519682478682
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,21206,139,1.25 [0.96-1.62],0.0976531230359247
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,23508,232,1.06 [0.87-1.30],0.5527838468045609
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23056,66,1.40 [0.96-2.03],0.0774984957755196
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15360,55,1.87 [1.23-2.85],0.0034208414011075
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23239,977,1.37 [1.24-1.51],3.66525521902381e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22286,269,1.07 [0.89-1.29],0.4489380273865141
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,21423,281,1.26 [1.05-1.51],0.0144978014807111
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23156,240,1.23 [1.01-1.49],0.0420359266416599
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10252,115,1.26 [0.95-1.68],0.1130649252469724
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16422,89,1.03 [0.74-1.42],0.8729535170263517
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,23393,141,1.18 [0.91-1.52],0.2171688725894357
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,17770,90,1.30 [0.94-1.81],0.1083422836204034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22192,200,0.96 [0.78-1.20],0.7459946950918896
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,23166,96,1.45 [1.06-1.97],0.0206184148636208
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22642,110,0.99 [0.74-1.32],0.9405264429141657
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18205,525,1.13 [0.99-1.29],0.0763377361975672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22113,121,1.32 [1.00-1.75],0.0526973618566559
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23126,121,1.31 [0.99-1.73],0.0605784544871067
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,22210,218,1.14 [0.93-1.40],0.2108792934006884
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,22769,777,1.07 [0.96-1.20],0.2026291194032224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,17941,261,1.03 [0.85-1.25],0.7542251420606888
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22048,56,1.15 [0.76-1.72],0.506477288574058
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23324,131,1.81 [1.39-2.36],1.0780964407152163e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,21910,93,3.36 [2.49-4.53],1.6664539432544758e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,22098,48,1.12 [0.72-1.74],0.6164605722105798
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23359,218,0.95 [0.78-1.17],0.6350144002686159
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,23366,1578,1.09 [1.01-1.18],0.0266650907129987
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,22140,90,1.11 [0.80-1.54],0.5209323227572805
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23188,65,0.96 [0.66-1.40],0.8351346143271232
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22126,76,1.07 [0.75-1.52],0.699948855194966
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,22886,223,0.98 [0.80-1.20],0.8707420747160951
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19921,1923,1.11 [1.03-1.19],0.0050866821501645
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,23422,170,1.15 [0.91-1.45],0.2547615015099596
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,23384,852,1.17 [1.06-1.30],0.0029243388256172
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21561,3881,1.12 [1.07-1.18],7.85446644047867e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23168,505,1.12 [0.98-1.28],0.1088555433832573
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23474,404,1.02 [0.87-1.18],0.8381184420499183
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22770,107,1.22 [0.91-1.64],0.1854183797897972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22630,65,0.91 [0.63-1.33],0.6300919891830745
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23213,1396,1.16 [1.07-1.26],0.0003320373140527
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22651,107,0.79 [0.59-1.05],0.1063294217872833
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23166,1174,1.09 [1.00-1.19],0.0533741884592963
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19352,3019,0.98 [0.93-1.04],0.4578818377360469
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17944,264,1.26 [1.04-1.52],0.0177134914965057
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23411,207,1.15 [0.93-1.43],0.1893724177354676
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23451,46,0.95 [0.61-1.47],0.8064160132730137
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22685,153,1.89 [1.48-2.41],3.170217596491252e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16512,179,0.93 [0.75-1.17],0.5523962693820672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18096,416,1.18 [1.01-1.37],0.0352353085145607
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,18044,364,1.20 [1.02-1.40],0.0296847035953701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19808,2128,1.11 [1.04-1.19],0.0016433595917218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18274,594,1.23 [1.08-1.39],0.0013561789592923
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18001,7901,1.03 [1.00-1.07],0.0584494030042813
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,22977,1160,1.09 [1.00-1.20],0.0508138754105731
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22706,43,1.76 [1.12-2.78],0.0149229864507131
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17285,1223,0.97 [0.89-1.06],0.4811448977092273
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22616,84,1.46 [1.04-2.03],0.0268245550575906
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,21505,3507,1.04 [0.99-1.10],0.1250624665685691
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,23454,43,0.94 [0.60-1.49],0.8005978261326865
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,16379,46,1.93 [1.24-3.02],0.0038658242092227
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,19620,1622,1.01 [0.94-1.10],0.7117814636171101
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18194,196,1.04 [0.84-1.30],0.7064281133621535
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16422,89,1.30 [0.94-1.80],0.1131248732431902
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21923,106,3.34 [2.53-4.41],1.965663267744597e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16598,265,1.29 [1.07-1.55],0.0082914977104874
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23483,372,1.13 [0.96-1.32],0.1315007883197947
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22722,672,1.24 [1.10-1.39],0.0004401260966854
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22929,879,1.17 [1.05-1.29],0.0033264849476663
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17889,209,1.07 [0.86-1.32],0.5516282305948217
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,18293,613,1.18 [1.04-1.34],0.0091752722691895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23473,112,1.02 [0.76-1.36],0.9132922131948252
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18073,75,1.03 [0.72-1.47],0.8882760100501516
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17742,1409,1.02 [0.94-1.10],0.6847695935489186
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22251,259,1.24 [1.02-1.50],0.0286395003985107
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22113,121,0.98 [0.74-1.29],0.8788790990049715
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18187,1854,1.00 [0.93-1.08],0.9575839251122747
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21741,5408,1.01 [0.97-1.06],0.5476904620203981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22615,176,1.05 [0.83-1.32],0.691446265401315
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,23214,682,1.15 [1.03-1.30],0.0175366619678493
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18410,730,1.12 [1.00-1.25],0.0596919304187188
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22134,142,1.26 [0.97-1.63],0.0805866293887032
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23405,335,0.95 [0.80-1.12],0.5343786189469443
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18479,799,1.08 [0.97-1.21],0.154984025496079
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22988,1171,1.10 [1.00-1.20],0.0469718380924944
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22839,176,1.14 [0.91-1.44],0.2564270228062238
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17949,1616,1.08 [1.00-1.17],0.0453916517480454
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19526,1846,1.20 [1.12-1.29],6.199644579666282e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22628,96,1.95 [1.43-2.66],2.18631086894721e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22819,769,1.23 [1.10-1.37],0.0002739443668799
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16680,347,1.11 [0.94-1.31],0.2157454143238915
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23442,55,1.05 [0.70-1.58],0.797137489759323
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16803,470,1.20 [1.04-1.38],0.0137312912818292
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21980,163,1.04 [0.82-1.33],0.7365852034674714
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23510,41,0.83 [0.52-1.32],0.4278728823551004
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22670,104,0.93 [0.69-1.25],0.6456668088707516
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,22095,45,1.03 [0.65-1.63],0.903648044879164
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17971,291,1.18 [0.99-1.42],0.0702725149659482
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22195,145,1.08 [0.84-1.39],0.5586055486452175
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22171,121,1.26 [0.95-1.67],0.10302371358835
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,18367,369,0.88 [0.75-1.03],0.1232794443917242
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16490,157,1.08 [0.85-1.39],0.5228944720373319
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,18256,258,1.21 [1.00-1.47],0.0515734697508244
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,16404,71,1.72 [1.19-2.48],0.0035794843887605
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23448,324,1.11 [0.94-1.32],0.2283845888985545
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23207,66,0.91 [0.63-1.32],0.6276926314363145
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21550,94,0.91 [0.66-1.25],0.5654085868104071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22798,755,1.20 [1.07-1.34],0.0014526398362215
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22244,201,1.21 [0.97-1.49],0.0857589222026569
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21927,471,1.50 [1.30-1.72],2.5570472540920546e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23231,266,1.00 [0.83-1.21],0.9942208451092523
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23434,469,1.10 [0.96-1.27],0.1713294928377209
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23010,45,0.97 [0.61-1.53],0.8966872695389244
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22057,3151,1.15 [1.09-1.22],5.446820749045592e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23085,403,1.04 [0.89-1.21],0.6217803318210073
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22974,292,1.01 [0.85-1.21],0.9024989796468316
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23067,1024,1.18 [1.08-1.30],0.0005182444170402
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23514,30,1.56 [0.90-2.71],0.1128238703024152
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21479,23,1.72 [0.92-3.21],0.0878533993405706
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22740,58,1.06 [0.71-1.59],0.7846092446814202
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23226,261,0.99 [0.81-1.19],0.8773731181584868
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21936,480,1.23 [1.07-1.42],0.0042363187084568
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21534,78,1.17 [0.82-1.66],0.3930478683304809
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23457,83,1.10 [0.78-1.53],0.5913816839436544
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22256,213,1.41 [1.15-1.74],0.0012041747864533
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23355,214,1.26 [1.02-1.55],0.0332740525767166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23036,71,1.59 [1.11-2.28],0.0123143006111961
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21520,64,1.48 [1.00-2.17],0.0473431481973052
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23076,1620,1.21 [1.12-1.30],1.4711870873833572e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21975,519,1.19 [1.04-1.36],0.0129503219852085
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21537,81,1.22 [0.87-1.73],0.2524061449977013
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23433,292,1.21 [1.01-1.45],0.0337962244139526
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23020,55,1.09 [0.72-1.64],0.6933760008543313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23397,256,1.16 [0.96-1.40],0.1356959873308651
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23468,344,1.12 [0.95-1.32],0.1903860364855817
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21543,87,0.89 [0.64-1.24],0.5063982795728845
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21721,265,0.87 [0.72-1.05],0.1345318640327353
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23461,337,1.11 [0.93-1.31],0.2473553731523137
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21724,268,1.55 [1.29-1.87],3.340064038782526e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23499,125,0.97 [0.74-1.27],0.8141364940705467
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20305,92,1.22 [0.89-1.67],0.2158669732490841
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21468,4715,1.00 [0.96-1.05],0.8684978607698
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20084,3331,1.00 [0.95-1.06],0.8641828505678452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20286,73,0.79 [0.56-1.12],0.1899938465004444
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20664,151,1.15 [0.90-1.48],0.2546618944538071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20655,142,1.00 [0.77-1.29],0.9949417724498092
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23328,66,0.83 [0.58-1.19],0.3145025254061494
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20591,78,1.17 [0.82-1.66],0.3893822905699542
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17611,858,0.98 [0.89-1.10],0.779997459708679
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23406,145,1.22 [0.94-1.58],0.1276987979956674
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20779,266,1.12 [0.93-1.35],0.2338743148239028
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20024,6186,1.02 [0.98-1.06],0.4396253976887099
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22477,90,1.19 [0.86-1.63],0.2954566586331199
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20377,164,0.98 [0.77-1.25],0.8747840930587854
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20644,431,0.85 [0.74-0.98],0.0283714981739032
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22718,2205,1.06 [0.99-1.13],0.1055649528477395
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20575,362,0.90 [0.77-1.06],0.2162655866636861
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20266,53,0.80 [0.53-1.20],0.2748695678516404
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20306,93,0.79 [0.58-1.07],0.133563431765192
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23211,29,0.79 [0.45-1.38],0.4037684398688547
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18194,1441,0.98 [0.91-1.07],0.6999538465586292
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17719,966,0.90 [0.82-1.00],0.0453105294314908
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23393,953,0.90 [0.82-0.99],0.0382993739075366
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16801,48,1.00 [0.64-1.56],0.9926854229758884
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16833,80,1.04 [0.74-1.47],0.8136593355783384
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20483,270,0.95 [0.79-1.14],0.5547725857970629
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17374,621,0.99 [0.88-1.12],0.9128526271420928
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20554,41,1.94 [1.20-3.13],0.0064655194469745
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21036,523,1.06 [0.93-1.21],0.3904174679214509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20777,264,1.09 [0.90-1.31],0.3847343817040135
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17333,580,1.01 [0.89-1.15],0.8572079322854987
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20278,65,1.22 [0.83-1.78],0.3064835670410992
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20265,52,1.10 [0.72-1.68],0.6525797700936016
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22482,95,1.58 [1.15-2.15],0.0041891921391806
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23236,849,1.31 [1.18-1.45],5.486847151000439e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22784,397,1.41 [1.21-1.65],1.0863345991164297e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23441,282,1.07 [0.89-1.29],0.4412539556500223
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18616,1863,1.03 [0.96-1.11],0.3548889170324831
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16805,52,0.81 [0.53-1.23],0.3155162385849616
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20294,81,1.00 [0.71-1.40],0.9911518198919368
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16809,56,0.83 [0.55-1.26],0.3741257462969228
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16799,46,1.01 [0.64-1.59],0.956282787899038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22564,177,1.00 [0.79-1.25],0.9676763169022924
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22545,158,1.42 [1.11-1.81],0.0056834844612323
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23489,86,1.22 [0.88-1.70],0.2396534822091452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22030,1517,1.07 [0.99-1.15],0.1065162230868897
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20281,68,0.99 [0.69-1.42],0.9500242681215898
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16793,40,0.95 [0.58-1.55],0.8375073528511656
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21119,606,1.09 [0.96-1.23],0.1934489033432452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18445,1692,1.03 [0.95-1.11],0.4753975981248952
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23234,52,0.90 [0.59-1.38],0.6318557183365366
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23506,60,0.96 [0.65-1.42],0.8357690094046901
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20294,81,1.10 [0.78-1.55],0.5826034239362825
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21185,972,1.09 [0.98-1.20],0.0980204360235886
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20307,94,1.03 [0.75-1.41],0.8536322619452898
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17935,1182,1.00 [0.92-1.10],0.9210949491091284
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22465,78,0.90 [0.64-1.26],0.5271714855633991
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20257,44,0.96 [0.61-1.51],0.8465252883253587
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20621,108,1.07 [0.79-1.44],0.6642215238981672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20709,496,1.02 [0.89-1.17],0.7451100490940021
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23375,193,1.14 [0.91-1.42],0.2632235002463171
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20992,479,1.17 [1.02-1.34],0.0288470046057855
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23450,276,1.07 [0.89-1.29],0.4826318645294513
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23509,39,0.98 [0.60-1.61],0.951266887851515
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20361,148,0.76 [0.60-0.97],0.0272070063774627
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19297,569,1.13 [0.99-1.28],0.0671412438968877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20689,476,1.24 [1.08-1.42],0.002812339780432
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20541,328,0.88 [0.74-1.04],0.1270219256521466
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16782,29,0.97 [0.54-1.72],0.9047740729575834
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18982,2229,0.97 [0.91-1.03],0.3217491455751421
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17201,448,1.02 [0.88-1.18],0.8372227849483166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23346,164,1.15 [0.90-1.47],0.2535659891748736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23451,48,1.59 [1.02-2.47],0.0399348817888992
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21566,45,0.91 [0.57-1.44],0.6765392369114838
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16815,62,0.93 [0.63-1.38],0.7314392762928474
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20600,87,0.89 [0.64-1.23],0.4650227932724229
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17043,290,1.08 [0.90-1.30],0.3863280028513649
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20490,277,0.90 [0.75-1.08],0.2535506523412736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20726,213,1.08 [0.88-1.33],0.458997234087666
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20603,90,1.26 [0.91-1.75],0.1629992880994257
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18692,31,0.98 [0.56-1.71],0.9409637001824194
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23510,40,1.06 [0.65-1.73],0.8094648124370556
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20742,529,0.95 [0.83-1.08],0.41727703137666
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23201,19,1.25 [0.61-2.53],0.5426138567938006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22461,2248,0.98 [0.92-1.05],0.6262733335911395
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20317,104,1.10 [0.81-1.48],0.5477189682035399
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21009,496,1.07 [0.93-1.23],0.3479777891257141
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22483,192,1.05 [0.84-1.31],0.6629318282167483
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20641,128,1.00 [0.77-1.32],0.973067479255026
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21800,1287,1.05 [0.97-1.15],0.2403629283781484
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21321,808,1.04 [0.94-1.16],0.4297105157309608
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20255,42,0.83 [0.52-1.33],0.4444934947887506
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23218,36,1.21 [0.73-2.01],0.459184601520981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20330,117,0.94 [0.71-1.24],0.6477540950142229
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20234,21,2.31 [1.20-4.48],0.0127646041455554
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16812,59,1.35 [0.91-2.01],0.1412272412385045
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22542,1858,1.30 [1.21-1.40],6.729564551114579e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23055,403,1.04 [0.90-1.21],0.5870606544918614
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22790,138,0.82 [0.63-1.06],0.1222032319239685
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22204,1520,1.56 [1.44-1.69],5.663270954612874e-28
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23271,82,2.56 [1.83-3.58],4.226665827043535e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23251,356,1.08 [0.91-1.27],0.3843582176105948
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,20676,207,0.99 [0.80-1.22],0.8982020876856449
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,20787,103,2.51 [1.85-3.39],2.2360445584998675e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22265,3293,1.06 [1.01-1.12],0.0267045344296111
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21190,5531,1.12 [1.08-1.17],4.9878382007246533e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23291,102,2.07 [1.54-2.79],1.8668826874923843e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19176,204,1.22 [0.98-1.51],0.0701252321631616
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20791,371,1.06 [0.90-1.24],0.4895961885353685
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21554,2582,1.09 [1.02-1.15],0.0078896811092972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19205,233,1.02 [0.84-1.25],0.8104150297799564
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20544,75,1.51 [1.06-2.15],0.0229280337039231
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19078,106,0.91 [0.68-1.22],0.5192398262149247
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23512,61,0.79 [0.53-1.16],0.2277344711151623
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23518,57,0.89 [0.59-1.35],0.5911742261642563
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22696,2227,1.13 [1.06-1.21],0.0001748679191626
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21408,939,1.12 [1.01-1.24],0.0273356126121916
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23454,559,1.11 [0.98-1.27],0.1041764931441406
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19279,307,1.17 [0.98-1.39],0.0752820601569502
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19252,280,1.03 [0.85-1.23],0.788902856920794
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19204,232,1.07 [0.88-1.32],0.4852033852272797
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23508,46,1.30 [0.83-2.05],0.2502675388734267
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21994,1525,1.23 [1.13-1.33],4.036130787695912e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20836,416,1.09 [0.94-1.27],0.2499072239816737
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23085,190,1.14 [0.92-1.43],0.2368279239008235
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23249,60,1.38 [0.93-2.05],0.1056896569032096
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19237,265,1.00 [0.83-1.21],0.9788047844108332
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23225,2805,1.30 [1.23-1.38],8.550803050279289e-19
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20494,74,1.98 [1.39-2.82],0.0001639353573021
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20839,155,1.45 [1.13-1.86],0.0030790865879469
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22728,76,1.10 [0.78-1.56],0.5877117996868458
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20761,292,0.99 [0.83-1.19],0.9136907758282818
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23171,519,1.00 [0.87-1.14],0.9469108442319256
